Fitzgerald Kevin Joseph - Insider Transactions
Insider Type
individual
Companies
1
Average
116,942
Total Txns
86
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 27 | -27 | 0.00 | 7,000,192.89 | -7,000,192.89 |
| 2025 | 0 | 59 | -59 | 0.00 | 3,056,839.94 | -3,056,839.94 |
| Total: | 0 | 86 | 10 | 0.00 | 10,057,032.83 | -10,057,032.83 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
450.81 USD |
449 Sold |
202,414 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
449.79 USD |
207 Sold |
93,107 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
453.77 USD |
273 Sold |
123,879 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
451.86 USD |
276 Sold |
124,713 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
447.92 USD |
47 Sold |
21,052 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
452.69 USD |
555 Sold |
251,243 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
455.82 USD |
60 Sold |
27,349 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
454.84 USD |
203 Sold |
92,333 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
448.77 USD |
150 Sold |
67,316 USD |
01/10/2025 | 02/10/2025 |
| Alnylam Pharmaceuticals, Inc. Common Stock US02043Q1076 |
446.53 USD |
96 Sold |
42,867 USD |
01/10/2025 | 02/10/2025 |